Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Masters of Science in Medical Biophsics - Establishing Metabolic Biomarkers of Early Stage Alzheimer's Disease Using Magnetic Resonance Imaging Techniques

EF 2022-23

Résumé
Alzheimer's Disease (AD) is an irreversible neurodegenerative disease that is rapidly gaining prelevance in Canada. Affected individuals are often not diagnosed with AD until they have demonstrated substantial cognitive deficits, greatly dimishing their quality of life. In order to facilitate earlier diagnosis and aid in the development of effective treatments, a better understanding of AD etiology, in the early stages of the disease (i.e., before a clincial diagnosis is received) is needed. Thus, there is motivation to establish sensitive and specific biomarkers, and a means to quantify them, that can be used to screen high risk individuals before the onset of clinical symptoms. The Tg344F-AD rat model is used to investigate the physiological hallmarks of AD (i.e., amyloid pathology, tau inclusions and frank neuronal loss). It has been found that while the aforementioned changes are often subtle and hard to detect clinically, they are coupled to metabolic changes that can be non-invasively quantified with functional Magnetic Resonance Imaging (fMRI) techniques). The proposed research will be a continuation of efforts to map global and regional changes in brain metabolism that precede the severe cognitive decline associated with AD. The output will be not only a better understanding of AD etiology, but also the development of new techniques of non-invasive diagnosis that can translate to clinical use in the human patient population.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486224
Name
Pineau Emma
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Masters of Science in Medical Biophsics - Establishing Metabolic Biomarkers of Early Stage Alzheimer's Disease Using Magnetic Resonance Imaging Techniques
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Diagnostic Procedures; Functional Imaging; Magnetic Resonance Imaging; Medical Imaging; Metabolism; Microvasculature; Non-Invasive Clinical Procedures; Quantifying Neurodegeneration; Understanding Brain Function
Abstract
Alzheimer's Disease (AD) is an irreversible neurodegenerative disease that is rapidly gaining prelevance in Canada. Affected individuals are often not diagnosed with AD until they have demonstrated substantial cognitive deficits, greatly dimishing their quality of life. In order to facilitate earlier diagnosis and aid in the development of effective treatments, a better understanding of AD etiology, in the early stages of the disease (i.e., before a clincial diagnosis is received) is needed. Thus, there is motivation to establish sensitive and specific biomarkers, and a means to quantify them, that can be used to screen high risk individuals before the onset of clinical symptoms. The Tg344F-AD rat model is used to investigate the physiological hallmarks of AD (i.e., amyloid pathology, tau inclusions and frank neuronal loss). It has been found that while the aforementioned changes are often subtle and hard to detect clinically, they are coupled to metabolic changes that can be non-invasively quantified with functional Magnetic Resonance Imaging (fMRI) techniques). The proposed research will be a continuation of efforts to map global and regional changes in brain metabolism that precede the severe cognitive decline associated with AD. The output will be not only a better understanding of AD etiology, but also the development of new techniques of non-invasive diagnosis that can translate to clinical use in the human patient population.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pineau, Emma
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~